Average Co-Inventor Count = 4.59
ph-index = 21
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (62 from 669 patents)
2. Incyte Holdings Corporation (25 from 147 patents)
3. Bristol-Myers Squibb Pharma Company (5 from 234 patents)
4. Bristol-Myers Squibb Compnay (1 from 3,685 patents)
5. Dupont Pharmaceuticals Company (1 from 106 patents)
69 patents:
1. 12516065 - Tertiary alcohols as PI3K-γ inhibitors
2. 12421197 - Aminopyrazine derivatives as PI3K-γ inhibitors
3. 12201636 - Heterocyclylamines as PI3K inhibitors
4. 12187725 - Tricyclic urea compounds as JAK2 V617F inhibitors
5. 12173006 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
6. 12152033 - Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders
7. 12084430 - Tricyclic urea compounds as JAK2 V617F inhibitors
8. 12030885 - Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors
9. 11958861 - Spirocyclic lactams as JAK2 V617F inhibitors
10. 11926630 - Tertiary alcohols as PI3K-γ inhibitors
11. 11819505 - Heterocyclylamines as PI3K inhibitors
12. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors
13. 11773102 - Heterocyclic compounds as PI3K-γ inhibitors
14. 11661422 - Tricyclic urea compounds as JAK2 V617F inhibitors
15. 11433071 - Heterocyclylamines as PI3K inhibitors